Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOnce you open a Mounjaro KwikPen, the medicine inside remains usable for up to 21 days, provided it is stored correctly at room temperature (below 30°C) or returned to the fridge. After that 21-day window, any remaining doses should be discarded — even if the pen still looks full and the medicine appears unchanged. This is a prescription-only medicine, and questions about your specific situation are best put to the prescriber who oversees your treatment. The information below draws on the Mounjaro Summary of Product Characteristics (the Mounjaro SmPC on the eMC) and the NHS medicines page for tirzepatide.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro comes as a pre-filled KwikPen designed for once-weekly subcutaneous injection. Each pen contains four doses. The 21-day in-use period begins on the day you give yourself the very first injection from that pen, not the day you take it out of the fridge, not the day it arrives, but the day it is first used. That gives you three further weekly injections within the window, with a little buffer time built in. It is worth writing the date of first use on the pen label so you are never guessing.
Most people find the easiest routine is to inject on the same day each week. If your injection day is, say, a Monday, your four injections fall on Mondays at weeks one, two, three and four. Week four lands on day 22 (one day outside the 21-day window) so in practice many people use all four doses comfortably within the limit. If your schedule slips by a few days, keep an eye on that date you wrote on the barrel. For broader context on how the medicine works over time, our page on how long Mounjaro takes to work covers the treatment timeline in more detail.
Before a pen is opened, it must be kept refrigerated at 2–8°C. Once opened and in use, you have a choice: it can go back in the fridge, or it can stay at room temperature, as long as the temperature stays below 30°C. The exact permitted room-temperature window is stated in the Patient Information Leaflet and the SmPC on the eMC, always check those rather than relying on memory or a secondhand figure, because the licensed window is product-specific and matters.
A practical note: many people keep the pen in the fridge door, which is convenient and consistent. The fridge door is not the coldest spot, it avoids the risk of the pen rolling to the back of the shelf where temperatures can dip toward freezing. Freezing damages the medicine. If a pen has been frozen, even briefly, it should not be used. Equally, avoid leaving it in a warm car, on a sunny windowsill or in a gym bag on a hot day. The medicine is sensitive to heat as well as to cold. When in doubt about whether a pen has been exposed to an extreme, your prescriber or pharmacist is the right person to ask.
The question of how long you can keep Mounjaro once it has been opened also depends on this storage discipline, staying within the temperature range is as important as counting the days.
The 21-day rule is a maximum, not a guarantee. There are circumstances where a pen should be discarded before that deadline. Check the liquid in the pen window before each injection: it should be clear to slightly yellow and free from particles or cloudiness. If you see anything floating, if the colour has changed noticeably, or if the pen has been stored outside the permitted temperature range, do not use it. The NHS tirzepatide medicines page reinforces this: only use the medicine if it looks as expected.
Sharps disposal also forms part of responsible use. Used pens and needles should go into a sharps container rather than general household waste; your local council or GP surgery can advise on collection. A sharps container keeps disposal straightforward at home.
If you are ever unsure whether a pen is still fit for use (perhaps because of a power cut that affected the fridge, a journey abroad, or a longer-than-expected break between injections) do not inject on uncertainty. Contact the prescriber or pharmacist who manages your treatment. At nume, our clinical team is available seven days a week for exactly this kind of aftercare question. You can reach us via our contact page.
Understanding the 21-day window also shapes how you plan repeat prescriptions. If your weekly injection day is consistent, four doses fit neatly within three weeks, and ordering your next pen before the current one is exhausted keeps treatment continuous. Gaps in treatment are something to discuss with your prescriber rather than manage independently, and the same applies to any dose changes. Our page on how long Mounjaro lasts covers the broader treatment duration question, which is separate from the in-use storage window discussed here.
For anyone thinking about the full picture of private treatment (including what is involved in getting a prescription in the first place) the Mounjaro treatment overview is a good starting point, and if you are stocking up or managing deliveries, our guide on how long Mounjaro lasts unopened explains what the shelf life looks like before a pen is ever first used. And if the question of ongoing cost is on your mind, our Mounjaro price page sets out what to expect from private treatment in the UK without surprises. Suitability for treatment is always determined by a prescriber through a clinical consultation. Speak to our prescribers if you would like to understand what that process involves for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.